Why Quest Diagnostics Stock Was Blasting Higher Today
Quest Diagnostics (NYSE: DGX) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price was up by more than 5% in late afternoon action, well ahead of the S&P 500 index's 0.8% gain at that point in the day.
The main reason for the bullish move wasn't hard to figure out -- Quest posted its fourth-quarter and full-year 2024 results this morning. Investors were particularly impressed by those quarterly numbers.
For the period, Quest's revenue amounted to $2.62 billion, representing a sturdy year-over-year increase of nearly 15%. Non-GAAP (adjusted) net income attributable to the company also rose, albeit at a more modest pace of 4% to hit $253 million. That shook out to $2.23 per share.
Source Fool.com
